- Home
- ACXP vs PAVM Comparison
ACXP vs PAVM Comparison
Compare ACXP & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- PAVM
- Stock Information
- Founded
- ACXP 2017
- PAVM 2014
- Country
- ACXP United States
- PAVM United States
- Employees
- ACXP 4
- PAVM N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- ACXP Health Care
- PAVM Health Care
- Exchange
- ACXP Nasdaq
- PAVM Nasdaq
- Market Cap
- ACXP 6.8M
- PAVM 8.0M
- IPO Year
- ACXP 2021
- PAVM 2016
- Fundamental
- Price
- ACXP $4.29
- PAVM $0.42
- Analyst Decision
- ACXP Strong Buy
- PAVM Strong Buy
- Analyst Count
- ACXP 3
- PAVM 1
- Target Price
- ACXP $143.67
- PAVM $19.00
- AVG Volume (30 Days)
- ACXP 73.5K
- PAVM 257.3K
- Earning Date
- ACXP 11-12-2025
- PAVM 11-12-2025
- Dividend Yield
- ACXP N/A
- PAVM N/A
- EPS Growth
- ACXP N/A
- PAVM N/A
- EPS
- ACXP N/A
- PAVM 0.83
- Revenue
- ACXP N/A
- PAVM $1,020,000.00
- Revenue This Year
- ACXP N/A
- PAVM N/A
- Revenue Next Year
- ACXP N/A
- PAVM $455.63
- P/E Ratio
- ACXP N/A
- PAVM $0.51
- Revenue Growth
- ACXP N/A
- PAVM N/A
- 52 Week Low
- ACXP $3.80
- PAVM $0.30
- 52 Week High
- ACXP $44.00
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- ACXP 38.73
- PAVM 39.49
- Support Level
- ACXP $4.02
- PAVM $0.42
- Resistance Level
- ACXP $4.27
- PAVM $0.49
- Average True Range (ATR)
- ACXP 0.53
- PAVM 0.04
- MACD
- ACXP 0.10
- PAVM -0.00
- Stochastic Oscillator
- ACXP 13.86
- PAVM 4.64
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.